Condition: Peripheral Arterial Disease · Sponsor: Avantec Vascular
The objective of this study is to establish reasonable assurance of safety and effectiveness of the Golazo® Peripheral Atherectomy System when used as indicated in 159 subjects with symptomatic infrainguinal peripheral arterial disease (PAD) in up to 20 investigational sites in the U.S.
This description comes directly from the study's public registry record.
Gene Reu · 858-945-0007 · GReu@avantecvascular.com
Jessi Maumee · 612-345-4544 · jessi.maumee@brightresearch.com
Always discuss trial participation with your own doctor first.
| HonorHealth Scottsdale Osborn Medical Center | Scottsdale, Arizona, United States | Withdrawn |
| Pulse Cardiovascular Institute | Scottsdale, Arizona, United States | Recruiting |
| Merced Vascular | Merced, California, United States | Recruiting |
| Palm Vascular Center | Fort Lauderdale, Florida, United States | Recruiting |
| First Coast Cardiovascular Institute | Jacksonville, Florida, United States | Recruiting |
| Radiology and Imaging Specialists of Lakeland | Lakeland, Florida, United States | Completed |
| Amavita Research Services | Miami, Florida, United States | Recruiting |
| Cardiovascular Consultants of South Georgia | Thomasville, Georgia, United States | Completed |
| Pacific Vascular Institute | ‘Aiea, Hawaii, United States | Recruiting |
| Baton Rouge General Hospital | Baton Rouge, Louisiana, United States | Recruiting |
| Cardiovascular Institute of the South - Houma | Houma, Louisiana, United States | Recruiting |
| Cardiovascular Institute of the South - Lafayette | Lafayette, Louisiana, United States | Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06321575